THMO Prakiraan rega marang bathi ThermoGenesis Holdings, Inc.

Cryopreservation patents and strict FDA oversight create significant barriers to entry for competitors, which determines the forward P/E multiple trend for ThermoGenesis (THMO). Collaboration with biobanks on tissue processing and independence from macroeconomic factors reinforce its status as a defensive asset. Meanwhile, the 0.00 metric reflects the current dynamics of investor expectations regarding the future earnings of ThermoGenesis.

THMO - Kapitalisasi marang proyeksi bathi thermogenesis.com ing rentang 04.07.2022 - 04.08.2024

Rincian metrik keuangan lan pasar Cesca Therapeutics (THMO)

- nilai saham lan prakiraan konsensus rega:

Bagan rega ThermoGenesis Holdings|THMO - Target median analis

- data kapitalisasi pasar:

Biji pasar ThermoGenesis Holdings, Inc.|THMO - Total Nilai Bisnis

- statistik nilai buku emiten:

Nilai Buku saben Saham ThermoGenesis|THMO - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku thermogenesis.com|THMO - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Total Utang marang Ekuitas ThermoGenesis|THMO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas ThermoGenesis|THMO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ThermoGenesis Holdings, Inc.|THMO - Utang jangka dawa|Utang jangka cendhak perusahaan ThermoGenesis|Rasio cepet thermogenesis.com

- statistik bathi lan rasio pasar:

THMO - Asil keuangan resik|Proyeksi bathi mangsa ngarep ThermoGenesis|THMO - Koefisien rega marang bathi|Pangali Forward P/E ThermoGenesis Holdings Inc.|THMO - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ThermoGenesis Holdings, Inc.|THMO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan ThermoGenesis|THMO - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan thermogenesis.com|THMO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep ThermoGenesis

Analisis fundamental perusahaan:ThermoGenesis Holdings

ThermoGenesis (THMO) global diversification within the biobank automation sector stabilizes cash flows, which is directly reflected in market expectations. The company's consensus forward P/E illustrates the cost of one dollar of projected earnings, allowing for an assessment of the premium paid for future growth relative to current market capitalization. This chart helps investors timely identify the gap between actual business growth rates and market prices.

Pesaing ThermoGenesis (THMO)

Rega marang bathi mangsa ngarep Abbott (ABT)|Kapitalisasi marang proyeksi bathi Thermo Fisher Scientific Inc.|GE Healthcare Corp - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep MTD (Mettler Toledo Inc)|Waters Corporation - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi bio-techne.com TECH|BRKR: Pangali Forward P/E|Prakiraan rega marang bathi Azenta Inc|Prakiraan rega marang bathi VREX|SMLR: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Butterfly Network, Inc. (BFLY)|Prakiraan rega marang bathi mesalabs.com MLAB|Pangali Forward P/E QSI (Quantum-Si Incorporated)|Nano-X Imaging (NNOX) - Rasio prakiraan rega marang bathi|Quanterix Corp - Pangali Forward P/E|MASS (908 Devices Corporation) - Rasio rega marang bathi mangsa ngarep|CV: Pangali Forward P/E|MXCT - Kapitalisasi marang proyeksi bathi|RPID (Rapid Micro Biosystems Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Seer Inc (SEER)|Pangali Forward P/E HYPR|Pangali Forward P/E FONAR Corporation Inc (FONR)|Rega marang bathi mangsa ngarep Daxor DXR|Spectral AI Inc. - Rega marang bathi mangsa ngarep|VIVS: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACON (Aclarion Inc)|AKYA: Pangali Forward P/E|Rasio prakiraan rega marang bathi Talis Biomedical Corporation (TLIS)|Rega marang bathi mangsa ngarep T2 Biosystems, Inc.